152 related articles for article (PubMed ID: 37530512)
1. Platinum(IV) combo prodrugs containing cyclohexane-1
Gabano E; Gariboldi MB; Marras E; Barbato F; Ravera M
Dalton Trans; 2023 Aug; 52(32):11349-11360. PubMed ID: 37530512
[TBL] [Abstract][Full Text] [Related]
2. trans,cis,cis-bis(benzoato)dichlorido(cyclohexane-1R,2R-diamine)platinum(IV): a prodrug candidate for the treatment of oxaliplatin-refractory colorectal cancer.
Gandin V; Marzano C; Pelosi G; Ravera M; Gabano E; Osella D
ChemMedChem; 2014 Jun; 9(6):1299-305. PubMed ID: 24715720
[TBL] [Abstract][Full Text] [Related]
3. Pt(iv) complexes based on cyclohexanediamines and the histone deacetylase inhibitor 2-(2-propynyl)octanoic acid: synthesis, characterization, cell penetration properties and antitumor activity.
Gabano E; Rangone B; Perin E; Caron G; Ermondi G; Vallaro M; Gandin V; Marzano C; Barbanente A; Margiotta N; Ravera M
Dalton Trans; 2021 Apr; 50(13):4663-4672. PubMed ID: 33725031
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines.
Gabano E; Ravera M; Perin E; Zanellato I; Rangone B; McGlinchey MJ; Osella D
Dalton Trans; 2019 Jan; 48(2):435-445. PubMed ID: 30539948
[TBL] [Abstract][Full Text] [Related]
5. New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.
Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
Biochem Pharmacol; 2015 Jun; 95(3):133-44. PubMed ID: 25888926
[TBL] [Abstract][Full Text] [Related]
6. Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer.
Sabbatini M; Zanellato I; Ravera M; Gabano E; Perin E; Rangone B; Osella D
J Med Chem; 2019 Apr; 62(7):3395-3406. PubMed ID: 30879295
[TBL] [Abstract][Full Text] [Related]
7. Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules.
Babu T; Sarkar A; Karmakar S; Schmidt C; Gibson D
Inorg Chem; 2020 Apr; 59(7):5182-5193. PubMed ID: 32207294
[TBL] [Abstract][Full Text] [Related]
8. An unsymmetric cisplatin-based Pt(iv) derivative containing 2-(2-propynyl)octanoate: a very efficient multi-action antitumor prodrug candidate.
Gabano E; Ravera M; Zanellato I; Tinello S; Gallina A; Rangone B; Gandin V; Marzano C; Bottone MG; Osella D
Dalton Trans; 2017 Oct; 46(41):14174-14185. PubMed ID: 28984330
[TBL] [Abstract][Full Text] [Related]
9. Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells.
Karmakar S; Kostrhunova H; Ctvrtlikova T; Novohradsky V; Gibson D; Brabec V
J Med Chem; 2020 Nov; 63(22):13861-13877. PubMed ID: 33175515
[TBL] [Abstract][Full Text] [Related]
10. Design of enzymatically cleavable prodrugs of a potent platinum-containing anticancer agent.
Ding S; Pickard AJ; Kucera GL; Bierbach U
Chemistry; 2014 Dec; 20(49):16164-73. PubMed ID: 25303639
[TBL] [Abstract][Full Text] [Related]
11. Cis,cis,trans-[Pt
Ravera M; Gabano E; Zanellato I; Rangone B; Perin E; Ferrari B; Bottone MG; Osella D
Dalton Trans; 2021 Mar; 50(9):3161-3177. PubMed ID: 33595015
[TBL] [Abstract][Full Text] [Related]
12. Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells.
Alessio M; Zanellato I; Bonarrigo I; Gabano E; Ravera M; Osella D
J Inorg Biochem; 2013 Dec; 129():52-7. PubMed ID: 24080480
[TBL] [Abstract][Full Text] [Related]
13. Activation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.
Thiabaud G; McCall R; He G; Arambula JF; Siddik ZH; Sessler JL
Angew Chem Int Ed Engl; 2016 Oct; 55(41):12626-31. PubMed ID: 27377046
[TBL] [Abstract][Full Text] [Related]
14. A new orally active antitumor 1R,2R-cyclohexanediamine-platinum(IV) complex: trans-(n-valerato)chloro(1R,2R-cyclohexanediamine) (oxalato)platinum(IV).
Kizu R; Nakanishi T; Hayakawa K; Matsuzawa A; Eriguchi M; Takeda Y; Akiyama N; Tashiro T; Kidani Y
Cancer Chemother Pharmacol; 1999; 43(2):97-105. PubMed ID: 9923814
[TBL] [Abstract][Full Text] [Related]
15. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
[TBL] [Abstract][Full Text] [Related]
16. Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands.
Novohradsky V; Zerzankova L; Stepankova J; Vrana O; Raveendran R; Gibson D; Kasparkova J; Brabec V
J Inorg Biochem; 2014 Nov; 140():72-9. PubMed ID: 25063910
[TBL] [Abstract][Full Text] [Related]
17. A valproic acid-modified platinum diimine complex as potential photosensitizer for photodynamic therapy.
Liu Z; Wang H; Zhang Z
J Inorg Biochem; 2021 Sep; 222():111508. PubMed ID: 34116426
[TBL] [Abstract][Full Text] [Related]
18. Docking and QSAR Studies of Aryl-valproic Acid Derivatives to Identify Antiproliferative Agents Targeting the HDAC8.
Martínez-Pacheco H; Ramírez-Galicia G; Vergara-Arias M; Gertsch J; Fragoso-Vazquez JM; Mendez-Luna D; Abujamra AL; Cristina CL; Cecilia RM; Mendoza-Lujambio I; Correa-Basurto J
Anticancer Agents Med Chem; 2017; 17(7):927-940. PubMed ID: 27774878
[TBL] [Abstract][Full Text] [Related]
19. Platinum(IV)-Loaded Degraded Glycol Chitosan as Efficient Platinum(IV) Drug Delivery Platform.
Lerchbammer-Kreith Y; Sommerfeld NS; Cseh K; Weng-Jiang X; Odunze U; Schätzlein AG; Uchegbu IF; Galanski MS; Jakupec MA; Keppler BK
Pharmaceutics; 2023 Mar; 15(4):. PubMed ID: 37111536
[TBL] [Abstract][Full Text] [Related]
20. Not the usual suspect - an unexpected organometallic product during the synthesis of cytotoxic platinum(II) complexes.
Maier T; Wutschitz J; Gajic N; Hejl M; Cseh K; Mai S; Jakupec MA; Galanski MS; Keppler BK
Dalton Trans; 2023 Nov; 52(44):16326-16335. PubMed ID: 37855721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
